Search for: "Endo Pharmaceuticals" Results 141 - 160 of 254
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 May 2019, 11:00 am by Kevin LaCroix
On May 18, 2015 Endo announced that it would be acquiring Par Pharmaceutical, another generic drug company for over $8 billion. [read post]
12 May 2019, 11:00 am by Kevin LaCroix
On May 18, 2015 Endo announced that it would be acquiring Par Pharmaceutical, another generic drug company for over $8 billion. [read post]
21 Oct 2021, 9:50 am by Simmons Hanly Conroy
For more details on any of the previous weeks in the New York opioid trial, visit past coverage: New York Opioid Trial Begins With Opening Arguments “Gremlins” Analogy Nets National Headlines New York Agrees to $1.18 Billion Settlement With Three Major Distributors Local Officials, First Responders Testify in New York Opioid Trial New York State Files Motion for Default Judgment Endo Pharmaceuticals Agrees to Settlement Remaining defendants in the trial include Teva… [read post]
12 Jan 2012, 1:51 pm by info@thomasjhenrylaw.com
Concerned consumers can call Endo Pharmaceuticals at 1-800-462-3636 with questions. [read post]
9 Jun 2014, 11:25 am
Last month, as reported by the Los Angeles Times, the California counties of Orange and Santa Clara sued Actavis, Endo Health Solutions Inc., Johnson & Johnson's Janssen Pharmaceuticals, Purdue Pharma and Teva Pharmaceutical Industries' Cephalon Inc. for causing the national prescription drug epidemic. [read post]
10 Aug 2022, 5:52 pm by Jeralyn
Bring back the pharmaceutical companies, get the DEA off its back, and let people in pain stop suffering. [read post]
17 May 2011, 8:24 am by Dennis Crouch
Background: Endo Pharmaceuticals has three pending patent applications that were all rejected on obviousness grounds and those rejections were affirmed by the BPAI. [read post]
21 Jul 2021, 12:44 pm by Jon L. Gelman
The manufacturers named in the complaint included Purdue Pharma and its affiliates, as well as members of the Sackler Family (owners of Purdue) and trusts they control; Janssen Pharmaceuticals and its affiliates (including its parent company Johnson & Johnson); Mallinckrodt LLC and its affiliates; Endo Health Solutions and its affiliates; Teva Pharmaceuticals USA, Inc. and its affiliates; and Allergan Finance, LLC and its affiliates. [read post]
11 Jan 2012, 5:36 pm by Mark Zamora
The opioid drugs are sold by Endo Pharmaceuticals as Percocet, Endocet, Opana and Zydone.source here: http://finance.yahoo.com/news/FDA-Novartis-recall-affect-apf-1013338683.html? [read post]
19 Mar 2018, 9:15 pm by Walter Olson
Nonetheless, the Ninth Circuit has lately upheld a California district attorney’s hiring of outside law firms on a contingency basis against such a challenge [Amanda Bronstad, The Recorder] And the Supreme Court last month refused to review a challenge to the New Hampshire attorney general’s use of contingency-fee counsel in an opioids suit against Endo Pharmaceuticals [Peter Hayes and Steven M. [read post]
10 Aug 2021, 6:20 am by Robert Kraft
” With the “settlements, only three drug manufacturers, Endo Health Solutions, Teva Pharmaceuticals USA and Allergan Finance, remain at trial. [read post]
28 Apr 2008, 8:46 pm
  The main conference, May 29-30, includes the following panel presentations: "Aligning IP Strategy and the Business -- Becoming a Resource Not a Roadblock," with Scott Brown, VP, General Counsel, Head of NIBR Patents, Novartis; Guy Donatiello, VP IP, Endo Pharmaceuticals; and Karen F. [read post]
17 May 2012, 5:57 am by Ray Mullman
Letters went to three pharmaceutical companies, Purdue Pharma, Endo Pharmaceuticals, and Johnson & Johnson, as well as five groups that support pain patients, physicians or research: the American Pain Foundation; American Academy of Pain Medicine; American Pain Society; Wisconsin Pain and Policy Study Group; and the Center for Practical Bioethics. [read post]
16 Jan 2018, 5:05 am by Scott McKeown
Endo Pharmaceuticals, Inc., Case IPR2014-00360 (PTAB June 27, 2014) (Paper 15). [read post]
14 Nov 2014, 5:44 pm
Other big manufacturers of transvaginal mesh products under scrutiny over their mesh implant devices include Johnson & Johnson and its Ethicon subsidiary, Bard Medical, and Endo Pharmaceutical’s American Medical Systems. [read post]